Q2 2026 Pfizer Inc Earnings Call Transcript
Good day, everyone, and welcome to Pfizer's second quarter 2026 earnings conference call. Today's call is being recorded.
At this time, I would like to turn the call over to Francesca DiMartino, Chief Investor Relations Officer and Senior Vice President. Please go ahead, ma'am.
Good morning, and welcome to Pfizer's earnings call. I'm Francesca DiMartino, Chief Investor Relations Officer. On behalf of the Pfizer team, thank you for joining us.
This call is being made available via audio webcast at pfizer.com.
Earlier this morning, we released our results for the second quarter of 2026 via a press release that is available on our website at pfizer.com.
I'm joined today by Dr. Albert Bourla, our Chairman and CEO Dave Denton, our CFO Cecile Gagant, our incoming interim CFO and Chris Boschoff, our Chief Scientific Officer. After their prepared remarks, we will open the call for questions.
Members of our leadership team will be
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
